Clinical data has the potential to transform the healthcare system and we are in the midst of a healthcare data revolution. However, health care data can be unique and difficult to measure. Aetion, the Real World Evidence Platform®, allows the healthcare industry to make critical decisions about treatments and drug development from a high-level and detailed perspective. Real World Evidence leads to informed decision-making and Aetion, founded by two physicians from Harvard, enables this with a focus on technology and big data. CEO Carolyn Magill shares more about how the company powers regulators, biopharma, payers, and health technology assessment (HTA) bodies, the company’s future plans, and Aetion’s Series B, which brings the total round size to $82B extension. Aetion has now raised a total of $93.6M across five rounds.
Johnson & Johnson Innovation
The notable startup fundings for the week ending 6/13/20 featuring funding details for NS8, Patient Ping, Squire, and much much more.
With so much going on in the city’s thriving ecosystem, it is easy to miss some of the happenings in the space. We keep you abreast of a few of things that you may have missed in NYC Tech News for the week ending 8/18 including the NYC startup fundings, NYC startup exits, and NYC Tech events including news for Axoni, Magnolia NeuroSciences, […]